XOROX

This brand name is authorized in Austria, Cyprus, Germany, Spain, Finland, Malta, Poland, Romania

Active ingredients

The drug XOROX contains one active pharmaceutical ingredient (API):

1 Aciclovir
UNII X4HES1O11F - ACYCLOVIR

Acyclovir is an antiviral agent with activity against herpes simplex virus and varicella-zoster virus. Acyclovir inhibits the DNA polymerase of the virus, preventing further proliferation.

Read about Aciclovir

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
XOROX Eye ointment Medicines Authority (MT) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01AD03 Aciclovir S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AD Antivirals
Discover more medicines within S01AD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 15897361
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 84832
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 419969
Country: MT Medicines Authority Identifier(s): MA1276/00101
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100410456
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W66624001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.